Back

AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and mortality: an AI-CVD study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic diseases (2) Cardiovascular Risk Assessment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Morteza Naghavi

HeartLung.AI, Houston (United States of America)

5 More presentations in this session

Presentation thumbnail
The underestimated risk of prediabetes on cardiovascular and renal outcomes in patients with heart failure
Doctor A. Hammer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Microvascular endothelial function predicts incident diabetes mellitus: the ELSA-Brasil cohort study
Doctor L. Brant (Belo Horizonte, BR)
Abstract Slides Video
Presentation thumbnail
The Relationship Between High-Sensitivity CRP and Cardiac Function in Patients with Type 2 Diabetes: A Cardiac Magnetic Resonance Study
Doctor A. Bojer (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
Inflammatory biomarkers suPAR, IL-6, and hsCRP and 13-year risk of mortality and MACE in type 2 diabetes: a prospective cohort study
Doctor H. Bahrami (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Time for cardiologists to focus on prediabetes: challenges in risk factor control
Assistant Professor V. Medovchshikov (Aktobe, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiometabolic diseases (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
AI-based algorithm for assessing coronary artery calcium score on contrast-enhanced cardiac computed tomography scans
thumbnail
Congress Presentation
Opportunistic screening of coronary artery calcification on non-gated conventional CT scans using artificial intelligence
thumbnail
Congress Presentation
Visual coronary artery calcium assessment on routine chest CT can readily and cheaply identify liver transplant recipients with a low cardiac risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources